1. Home
  2. SBLX vs AZTR Comparison

SBLX vs AZTR Comparison

Compare SBLX & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBLX
  • AZTR
  • Stock Information
  • Founded
  • SBLX 2017
  • AZTR 2014
  • Country
  • SBLX United States
  • AZTR United States
  • Employees
  • SBLX N/A
  • AZTR N/A
  • Industry
  • SBLX Telecommunications Equipment
  • AZTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBLX Consumer Discretionary
  • AZTR Health Care
  • Exchange
  • SBLX Nasdaq
  • AZTR Nasdaq
  • Market Cap
  • SBLX 4.0M
  • AZTR 4.2M
  • IPO Year
  • SBLX N/A
  • AZTR 2023
  • Fundamental
  • Price
  • SBLX $4.64
  • AZTR $0.49
  • Analyst Decision
  • SBLX
  • AZTR Strong Buy
  • Analyst Count
  • SBLX 0
  • AZTR 1
  • Target Price
  • SBLX N/A
  • AZTR $4.00
  • AVG Volume (30 Days)
  • SBLX 609.9K
  • AZTR 5.3M
  • Earning Date
  • SBLX 11-13-2025
  • AZTR 11-14-2025
  • Dividend Yield
  • SBLX N/A
  • AZTR N/A
  • EPS Growth
  • SBLX N/A
  • AZTR N/A
  • EPS
  • SBLX N/A
  • AZTR N/A
  • Revenue
  • SBLX $5,426.00
  • AZTR N/A
  • Revenue This Year
  • SBLX N/A
  • AZTR N/A
  • Revenue Next Year
  • SBLX N/A
  • AZTR N/A
  • P/E Ratio
  • SBLX N/A
  • AZTR N/A
  • Revenue Growth
  • SBLX N/A
  • AZTR N/A
  • 52 Week Low
  • SBLX $4.20
  • AZTR $0.47
  • 52 Week High
  • SBLX $15.28
  • AZTR $4.33
  • Technical
  • Relative Strength Index (RSI)
  • SBLX 41.56
  • AZTR 32.75
  • Support Level
  • SBLX $4.48
  • AZTR $0.47
  • Resistance Level
  • SBLX $4.99
  • AZTR $0.62
  • Average True Range (ATR)
  • SBLX 0.62
  • AZTR 0.08
  • MACD
  • SBLX -0.08
  • AZTR -0.02
  • Stochastic Oscillator
  • SBLX 6.96
  • AZTR 3.74

About SBLX StableX Technologies Inc. Common Stock

StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: